Pharma Pulse 11/20/24: Impact of ALZ on Heath Equity, Seasonal Flu Returns to Pre-Pandemic Levels, & More

The Impact of Alzheimer’s Disease Treatments on Health Equity
Could health system changes that improve patient access to medication have a positive effect on societal welfare?

Spread of Seasonal Flu Returns to Pre-Pandemic Levels After End of COVID-19 Global Emergency
Increased global capacity for surveillance could help monitor seasonal influenza to reduce the risk of vaccine mismatch and inform effective interventions.

Trump Wants RFK Jr. to ‘Go Wild’ on Healthcare. Investors Need Not Panic
The vaccine skeptic may find it hard to enact sweeping changes to American healthcare.

National Ataxia Foundation Hosts Congressional Briefing with Bill Nye, The Science Guy
The National Ataxia Foundation (NAF) partnered with members of Congress to host an informational meeting for legislators, their staff and other interested parties to provide education regarding Spinocerebellar Ataxia (SCA), a group of rare and debilitating hereditary neurodegenerative diseases that frequently impact multiple family members at the same time, with no cure or FDA-approved treatment.

EVERSANA on LinkedIn
Expanding Horizons! Last month, we announced the opening of our new office in Berlin, marking a significant step in our European expansion. As Mike Ryan explains in this interview with Pharmaceutical Executive, this move strengthens our ability to navigate diverse regulatory landscapes and deliver tailored solutions to meet local healthcare needs.

#GlobalExpansion #Pharmaceuticals #Berlin

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs